Robin Monotti
66.9K subscribers
15.8K photos
8.73K videos
625 files
30.1K links
Official Robin Monotti Channel
Donations:
robinmonotti.substack.com/
Group is @robinmggroup
We don't DM from this channel account.
Rule: Be polite & respectful.
Download Telegram
"Upon vascular injury, locally controlled haemostasis prevents life-threatening blood loss and ensures wound healing. Intracellular material derived from damaged cells at these sites will become exposed to blood components and could contribute to blood coagulation and pathological thrombus formation. So far, the functional and mechanistic consequences of this concept are not understood. Here, we present in vivo and in vitro evidence that different forms of eukaryotic and prokaryotic RNA serve as promoters of blood coagulation. Extracellular RNA was found to augment (auto-)activation of proteases of the contact phase pathway of blood coagulation such as factors XII and XI, both exhibiting strong RNA binding. Moreover, administration of exogenous RNA provoked a significant procoagulant response in rabbits. In mice that underwent an arterial thrombosis model, extracellular RNA was found associated with fibrin-rich thrombi [ BLOOD CLOTS ], and pretreatment with RNase (but not DNase) significantly delayed occlusive thrombus formation. Thus, extracellular RNA derived from damaged or necrotic cells particularly under pathological conditions or severe tissue damage represents the long sought natural “foreign surface” and provides a procoagulant cofactor template for the factors XII/XI-induced contact activation/amplification of blood coagulation. Extracellular RNA thereby reveals a yet unrecognized target for antithrombotic intervention, using RNase or related therapeutic strategies."
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1851071/
"Over a decade ago, we completed the Step and Phambili phase 2b studies that evaluated an Ad5 vectored HIV-1 vaccine administered in three immunisations for efficacy against HIV-1 acquisition. Both international studies found an increased risk of HIV-1 acquisition among vaccinated men."

Use of adenovirus type-5 vectored vaccines: a cautionary tale - The Lancet
https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)32156-5/fulltext
Forwarded from Deleted Account
While adenoviral vectors (Astra Zeneca and Johnson &Johnson) have been tested in far more people than mRNA vaccines, the technology has been used in only one commercial vaccine prior to covid: a rabies vaccine used to immunize wild animals.

https://cen.acs.org/pharmaceuticals/vaccines/Adenoviral-vectors-new-COVID-19/98/i19
"Dangerous side effects of genetically induced production
of SARS CoV-2 spike proteins
Wolfgang Wodarg 15.3.2021
 
Neither Coronaviruses nor their spikes do enter blood in uncomplicated infections. In more than 90% of all corona-infections immune barriers in the upper respiratory tract or local mucosa immunity will prevent this. This is the result of T-cell driven cross-immunity. (1)
We do not find such an immunity by analyzing antibodies, instead we would have to analyze many T- cell epitopes of corona viruses (2), which is an effort to big to be used for preventive public health reasons.
No matter, which new mutation of a virus will come, the cellular memory of the local immune system is able to recognize tens of different typical epitopes of each respiratory virus species, even then, when some of them have changed by mutations (2).
This seems to be true for all mild respiratory infections and not just for coronaviruses*.
In rare cases of insufficient local immunity, or by medical manipulations (intubation!) viruses happen to enter the blood and become targets of a stronger and more generalized immune defence with humoral and cellular traces (e.g. antibodies) and symptoms like fever or even hampered organ function (less than 1%) (3).
If coronaviruses reach blood, the effect of corona-Spikes within the blood system is well known to be the reason for complicated or deadly Corona infection courses. Some of them are seen as a direct effect in reaction with certain cell receptors, others are reported as secondary effects, happening when infected cells start reproducing new viruses.
 
All those reactions take place or start within some days or in the first weeks after the infection. Those effects may be the reason for the fact that even some younger patients are dying each year with atypical pneumonia, heart or central nervous complications after some infection with different flu viruses like Influenza A or B, Parainfluenza, human Metapneumovirus, RS-Virus, Coronavirus and many others.
 
It is well known that also virus-virus synergism as well as superinfections with bacteria or nosocomial infections may play an important role in those rare complications among children and younger adults. Very often there are other pathogenetic factors that lead to complications. All those cases have to be distinguished from elderly victims, where frailty und chronic diseases weaken the resistance against any additional infectious stress.
 
No matter, where those corona-spikes come from, whether they are part of whole viruses or just spike-proteins, produced by genetically programmed cells, in both cases dangerous reactions may result,  if they reach the patient’s blood vessels.
Again, a normal acute respiratory infection without fever or severer symptoms (> 99%) does not come along with corona-spike protein reaching the blood and does not initiate risky generalized immune alarms.
However when genetically engineered vectors or particles are injected into the upper arm muscle, natural immune barriers or systems of defence are bypassed.
There are not enough competent immune cells in the tissue of the m. deltoideus. And as soon as some closer cells in the muscle start to produce and present spike protein, there should be a strong and more and more generalizing local immune reaction with swellings and pain. This fits well with observed side effects of the ongoing experimental use of all genetically modifying injections.
It is unknown where the new self-made spike proteins remain, or whether parts of them could go with the blood. As there are many blood vessels in the muscle, it may happen often and easily, that part of the injected dose reaches the blood already during injection.
If this happens, the complications may be similar to those, coming along with hematogenous sowing during a complicated infection.
 
In such cases there are three possible risks of vaccination, that can have similar serious consequences and even may happen in combination with each other:
 

https://www.wodarg.com/english/
I am posting this again. It is an official UK government document. It is linked from here: https://www.gov.uk/government/publications/spi-m-o-summary-of-further-modelling-of-easing-restrictions-roadmap-step-2-31-march-2021

"SPI-M-O: Summary of further modelling of easing
restrictions – Roadmap Step 2
Date: 31st March 2021

32. The resurgence in both hospitalisations and deaths is dominated by those that have received two doses of the vaccine, comprising around 60% and 70% of the wave respectively. This can be attributed to the high levels of uptake in the most at-risk age groups, such that immunisation failures account for more serious illness than unvaccinated individuals. This is discussed further in paragraphs 55 and 56."

https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/975909/S1182_SPI-M-O_Summary_of_modelling_of_easing_roadmap_step_2_restrictions.pdf
Forwarded from The White Rose
Spotted in Belgravia, London

Step 1 - Buy a cheap Brother QL-810W, QL-800, QL-700, QL-600, QL-570, QL-550 or QL-500 label printer.

Step 2 - Download the latest sticker archive for free, pinned at the top of the White Rose Telegram channel (t.me/jointhewhiterose).

Step 3 - Print hundreds of stickers per minute, for DIRT cheap, from the comfort of your home.

Step 4 - Wake up the masses!

Everything you need to know about how to print our stickers can be found here:

t.me/jointhewhiterose

Don't forget to share everywhere.
Forwarded from Mike Yeadon
Hello everyone,
I’ve been told that Ian Brown had followed me on Twitter. I’m honestly honoured!
Thing is, I think his radar had spotted something was horribly wrong before many others.
I’d be chuffed to bits if I could be put in touch with Ian.
Cheers
Mike Yeadon
Forwarded from Mike Yeadon
I don’t think we can assume anything about “what they want” other than TOTAL CONTROL.

Once a vaccine passport system is up & running and with a majority of the adult population on it, it cannot be halted.

The validity algorithm of the VP (really the INvalidity & exclusion of the non vaccinated) will be steadily made harsher, in order to coerce people to get vaccinated.

Very quickly a 75% of a population vaccinated becomes >>90%. Then >>95%.

No one will bother to defend the unvaccinated. Soon everyone is vaccinated or severely marginalised.

Why this isn’t obvious to our stupid MPs, I don’t know.

Temporary? How would it be turned off? It won’t of course.
"COVID-19: Oxford jab scientist set for £20m windfall in 'New York flotation'
The scientist who led the development of the Oxford University-AstraZeneca coronavirus vaccine is on course for a payday of £20m through a stock market listing, according to reports.
Professor Sarah Gilbert owns just over 5% of a company she co-founded in 2016 called Vaccitech.
Vaccitech owns the technology behind the COVID-19 jab
The Oxford-Astra jab, while hailed as a first rate product, has hit bumps in the road over concerns about a possible link to blood clots in a small number of recipients.
Vaccitech's shareholders include Professor Gilbert's Oxford colleague, Professor Adrian Hill, the other co-founder who also has a stake of 5.2%.
GV, the venture capital fund of Google's parent firm Alphabet, has an interest of 12%.
The FT reported that the UK government also owned a stake though any interest was not listed in details lodged with Companies House."

https://news.sky.com/story/covid-19-oxford-jab-scientist-set-for-16320m-windfall-in-new-york-flotation-12269021
IAN BROWN COVERS JOHNNY OSBOURNE'S "TRUTH AND RIGHTS"

"Render your hearts and not your garments
The truth is there for who have eyes to see
Partiality has no place in this judgement
Remember the words of prophecy

Children, run come the truths and rights
That's what I'm about
You know the truths and rights
Teach it to the children
You know the truths and rights
Teach it to the children
Cause they should know
know know know know

Children say a little prayer
Every night before you go to sleep
Cause tomorrow is promised to no one
When you think it's peace and safety, Lord
It could be, it could be sudden destruction
Cause we know, yes we know

Render your hearts and not your garments
The truth is there for who have eyes to see
Partiality has no place in this judgement
Remember the words of prophecy

Children, run come the truths and rights
That's what I'm about
You know the truths and rights
Teach it to the children
You know the truths and rights
Teach it to the children

https://youtu.be/uaJiC6uwwZI
Forwarded from Little Durhamred
Calling all health professionals, health, public services & ex-armed forces who are planning to attend the london protest on the 24th April; there will be a group of us marching together in our uniforms.

Hoping that this will send a message that some of us are pushing back on the agenda & prepared to be counted, to make them question the mass coerced vaccination programme (& all that surrounds it)

And I’m hope it may encourage other workers to step up & speak out.

Please join if you are coming and would like to walk with us 🙏

Please if you join say hello & state what your job role is (or was) x

https://t.me/ukHWprotest
ANTIBODY DEPENDENT ENHANCEMENT (ADE) OR VACCINE ANTIBODY DEPENDENT ENHANCEMENT (VADE):

"Lessons from SARS and MERS vaccines

The genomes of SARS-CoV-2 and SARS-CoV share 79.6% sequence identity70, and they use the same receptor, angiotensin-converting enzyme 2 (ACE2), to enter cells71. Therefore, SARS vaccine-induced immune responses, which have already been studied, would be useful in the evaluation of COVID-19 candidate vaccines. In 2003, soon after isolation of SARS-CoV viral particles and release of the viral genome sequence, SARS vaccine design began. Similarly to COVID-19 vaccine developers, researchers first sought SARS vaccines based on inactivated virus, recombinant subunit proteins and recombinant vectors. 

A recombinant modified vaccinia virus Ankara vector expressing SARS-CoV S protein elicited a rapid and vigorous NAb response in ferrets; however, a strong inflammatory response in the liver of immunized ferrets occurred after challenge with SARS-CoV74,75. More studies then demonstrated that SARS vaccines, based on either inactivated virus or a recombinant vector, could induce eosinophils and TH2 cell-skewed immune responses on subsequent challenge with SARS-CoV in a mouse model76,77,78, which is reminiscent of RSV vaccine-induced ERD in infants. Similarly, an inactivated SARS-CoV vaccine and a SARS-CoV S protein-derived peptide vaccine both induced severer lung damage in rhesus macaques after SARS-CoV challenge79. A DNA vaccine encoding the S protein of SARS-CoV induced CD4+ and CD8+ T cell and NAb responses in a mouse model and in a phase I clinical trial80,81.
ADE was also observed in SARS vaccines. A SARS vaccine based on recombinant SARS-CoV S protein protected hamsters from SARS-CoV infection; however, the S protein-specific antibodies could mediate FcR-dependent entry into B cells in vitro82,83. Furthermore, diluted SARS-CoV S protein-specific antibodies resulted in increased virus infectivity and cytopathic effect in an HL-CZ human promonocyte cell line84. Except for the ADE, antibody-mediated unbalanced macrophage activation has been reported to be associated with obvious lung injury in vivo. Passive transfer of anti-S IgG abrogated wound-healing responses and promoted proinflammatory monocyte and macrophage recruitment and accumulation in the lungs of macaques after viral challenge, indicating that SARS-CoV S protein-specific antibodies could elicit pathogenic immune responses, as well as enhance disease severity after SARS-CoV infection24. Notably, the evidence for anti-S IgG-mediated ADE was observed only in vitro. Therefore, ADE seems a less critical issue than other antibody- and TH2 cell-mediated immunopathology in vivo.
MERS-CoV belongs to the genus Betacoronavirus, which also includes SARS-CoV and SARS-CoV-2. Since the virus was first identified in Saudi Arabia in 2012, many vaccine techniques, including subunit vaccines, viral vector and DNA-based vaccines, and inactivated and live attenuated vaccines, have been applied to develop MERS vaccines85. Many of them could induce adequate immune responses and protect vaccinated animals from subsequent MERS-CoV infection86. However, two studies independently reported that mice vaccinated with inactivated MERS-CoV developed TH2 cell-biased immune responses and increased eosinophil infiltrates after viral challenge87,88. Several lines of evidence have demonstrated that MERS S protein-specific antibodies are able to mediate ADE. A monoclonal antibody induced by recombinant MERS-CoV S1 bound to cell surface IgG FcR and mediated viral entry into HEK293T cells exogenously expressing FcRs and macrophages (induced from THP-1 monocytes) endogenously expressing FcRs through canonical viral receptor-dependent pathways89. Rabbits infected with MERS-CoV developed MERS-CoV S protein-specific antibodies without neutralizing activity and protection of animals against reinfection, and concerningly, MERS-CoV-reinfected rabbits showed enhanced pulmonary inflammation associated with complement activation90.
Overall, signs of VADE are less prominent for MERS vaccines than for SARS vaccines. Currently, one DNA MERS vaccine (INO-4700) and two viral-vectored MERS S protein-based vaccines have shown a favourable safety profile and induced humoral and cellular immune responses against MERS-CoV in phase I clinical trials"

https://www.nature.com/articles/s41579-020-00462-y#Sec11
"#4: THE "DATA GAPS" SUBMITTED TO THE FDA BY THE VACCINE MAKERS


When vaccine makers submitted their papers to the FDA for the Emergency Use Authorization (Note: An EUA is not the same as a full FDA approval), among the many "Data Gaps" they reported was that they have nothing in their trials to suggest they overcame that pesky problem of Vaccine Enhanced Disease.


They simply don't know--i.e. they have no idea if the vaccines they've made will also produce the same cytokine storm (and deaths) as previous attempts at such products.


As Joseph Mercola points out...


"Previous attempts to develop an mRNA-based drug using lipid nanoparticles failed and had to be abandoned because when the dose was too low, the drug had no effect, and when dosed too high, the drug became too toxic. An obvious question is: What has changed that now makes this technology safe enough for mass use?"



If that's not alarming enough, here are other gaps in the data--i.e. there is no data to suggest safety or efficacy regarding:


Anyone younger than age 18 or older than age 55

Pregnant or lactating mothers

Auto-immune conditions

Immunocompromised individuals

No data on transmission of covid

No data on preventing mortality from covid

No data on duration of protection from covid


Hard to believe right?


In case you think I'm making this up, or want to see the actual documents sent to the FDA by Pfizer and Moderna for their Emergency Use Authorization, you can check out this, or this respectively. The data gaps can be found starting with page 46 and 48 respectively.


For now let's turn our eyes to the raw data the vaccine makers used to submit for emergency use authorization.


#5: NO ACCESS TO THE RAW DATA FROM THE TRIALS


Would you like to see the raw data that produced the "90% and 95% effective" claims touted in the news?


Me too...


But they won't let us see that data.


As pointed out in the BMJ, something about the Pfizer and Moderna efficacy claims smells really funny.


There were “3,410 total cases of suspected, but unconfirmed covid-19 in the overall study population, 1,594 occurred in the vaccine group vs. 1,816 in the placebo group.”


Wait...what?


Did they fail to do science in their scientific study by not verifying a major variable?


Could they not test those "suspected but unconfirmed" cases to find out if they had covid?


Apparently not.


Why not test all 3,410 participants for the sake of accuracy?"

https://www.deconstructingconventional.com/post/18-reason-i-won-t-be-getting-a-covid-vaccine
A message to the public from Dr Tess Lawrie

Dr Lawrie appeals to the public to inform themselves on the evidence of the efficacy of ivermectin and share it ...

Dr Theresa Lawrie
Evidence-Based Medicine Consultancy Ltd Bath, United Kingdom
+44 7826 939464
e-bmc.co.uk

Vimeo https://vimeo.com/533986005/0d843fedf8

You can now find the urgent message to the public from Dr. Tess Lawrie with Italian, Spanish and French subtitles on #vimeo #ivermectin
Italian - https://t.co/yyM9ZRQjWr
Spanish - https://t.co/1uybQyMzu5
French - https://t.co/nuMvTLJ8xN
Already Had A COVID-19 Infection Or Think You Did? Don’t Rush To Get The Vaccine — It May Not Be Safe For You. | by Hooman Noorchashm | Feb, 2021 | Medium

"Once a person is naturally infected by a virus (any virus), antigens from that virus persist in the body for very long after viral replication has stopped and clinical signs of infection have resolved. So, when a vaccine reactivates an immune response in such recently infected persons, the tissues harboring the persisting viral antigen are targeted, inflamed and damaged by the immune response.

In the case of SARS-CoV-2, we know that the virus naturally infects the heart, the inner lining of blood vessels, the lungs and the brain. So, these are likely to be some of the critical organs that will contain persistent viral antigens in the recently infected — AND, following reactivation of the immune system by a vaccine, these tissues can be expected to be targeted and damaged.
If young and otherwise healthy persons, recently infected, could tolerate such an adverse side-effects of the vaccine, it is highly likely that many of the elderly and frail, or those with serious cardiovascular risk factors, would not.
So, I feel obliged to suggest, as a physician and immunologist, that any persons with “known or suspected” COVID-19 infections avoid or delay getting the COVID-19 vaccine.
Certainly, any elderly and frail persons and those with cardiovascular — or any person who suspects having been exposed to COVID-19 — should be screened for the virus and for COVID-19 IgG antibodies. If either of these screening tests are positive, these persons ought to delay or avoid being vaccinated.
Indiscriminate deployment of a vaccine treatment in the midst of an outbreak is highly likely to be a clinical and scientific error — and the United States public health agencies are allowing this error to occur, unmitigated.
Therefore, it is necessary for all responsible citizens and professionals to carefully consider whether naturally infected persons should get vaccinated indiscriminately."


https://noorchashm.medium.com/already-or-had-a-covid-19-infection-or-think-you-did-b282f9471605
Open Letter from Christian Leaders to the Prime Minister Concerning Vaccine Passport Proposals


Christian Leaders — Vaccine Passport Letter
https://vaccinepassportletter.wordpress.com/
Forwarded from Mike Yeadon
In response to news that “government may ask the under 30s to have a different vaccine than AZ”.

The other vaccines are dangerous too.
Not in everyone.
But none are close to safe enough to use as a public health prophylactic.

Vaccinating everyone will result in some young (& older) people DYING because they were vaccinated. These people were never at risk of death from covid19.

Ask yourself what kind of public health policy kills some citizens, unavoidably, in order to get everyone vaccinated?

Think! It’s so everyone can be bagged & tagged on a global ID system.

The perfect tool of totalitarian thug castes

Ask yourself why they want that total control. And what they might do with that power.

Yes, you’ve got it now.

So....do NOT permit a vaccines passports system to go live.

That marks the irreversibly ending of liberal democracy. I kid you not.

Just don’t say you weren’t warned, because you were. Repeatedly.

Dr Mike Yeadon
Prince Philip received the first Covid19 injection on the 9th January 2021. I can't find any confirmation of the date of the second injection. It would have been minimum 4 weeks later or around mid February. He was admitted to hospital on the 17th February 2021. That is possibly just after the second dose of presumably the Astrazeneca Oxford injection.